Clinical Trials Browser

Phase 1/2 × Meningioma × 64Cu-SARTATE × Clear all

NCT03936426 2020-04-20

Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™

Phase 1/2 Completed

Meningioma